Lydia Frick

Manager Market Access • SKC Beratungsgesellschaft mbH

Dr. Lydia Frick is a Manager Market Access at SKC Beratungsgesellschaft mbH, a leading strategic consultancy located in Hannover, Germany, covering full market access of pharmaceuticals and digital health applications in Germany and Europe. As a psychologist, natural scientist and market access expert, Lydia combines a deep understanding of the generation of clinical evidence with strong strategic insights from the perspectives of developers, HTA bodies, and payers.  

Lydia has a BSc and MSc in Psychology from the University of Goettingen and did her PhD in Cognitive Neuroscience at German Primate Center in Goettingen. She then started her career outside academia as a medical writer focusing on the compilation of value dossiers for the German AMNOG benefit assessment. Moving into strategic consulting, Lydia has gained extensive experience with market access including AMNOG and EU-HTA strategy, with a particular focus on orphan drugs and ATMPs.

Also speaking

Frank Luppino

President & Chief Executive Officer • Remedium Bio

William Shingler

Head of Patient and Cell Management • Autolus Therapeutics

Karen Moniz

Technical Director • ICCBBA

Event Info


Advanced Therapies Investment Summit

Find out more about the Investor Pre-Day taking place 10th September 2024.

2023 Sample Attendee List

Take a look at the sample attendee list for Advanced Therapies Europe 2023 here.